Kaesmacher, Johannes http://orcid.org/0000-0002-9177-2289
Chaloulos-Iakovidis, Panagiotis
Panos, Leonidas
Mordasini, Pasquale
Heldner, Mirjam R.
Kurmann, Christoph C.
Michel, Patrik
Hajdu, Steven D.
Ribo, Marc
Requena, Manuel
Maegerlein, Christian
Friedrich, Benjamin
Costalat, Vincent
Benali, Amel
Pierot, Laurent
Gawlitza, Matthias
Schaafsma, Joanna
Pereira, Vitor Mendes
Gralla, Jan
Fischer, Urs
Funding for this research was provided by:
Medtronic (ERP-2017-11049)
Article History
Received: 4 September 2018
Revised: 22 December 2018
Accepted: 25 December 2018
First Online: 8 January 2019
Compliance with ethical standards
:
: Dr. Fischer is a consultant for Medtronic and Stryker and Co-PI of the SWIFT DIRECT trial (Medtronic). Dr Gralla is a global principal investigator of STAR (Solitaire FR Thrombectomy for Acute Revascularisation), clinical event committee member of the PROMISE study (European Registry on the ACE Reperfusion Catheters and the Penumbra System in the Treatment of Acute Ischemic Stroke; Penumbra), and a principal investigator and consultant for the SWIFT DIRECT study (Medtronic) and receives Swiss National Science Foundation (SNSF) grants for magnetic resonance imaging in stroke. Dr Pierot serves as a consultant for Balt, Microvention, and Penumbra. Dr. Kaesmacher has received travel grants from Pfizer and Stryker and received research grants from the SAMW/Bangerter Foundation and the Swiss Stroke Society. Dr Ribo serves as a consultant for Medtronic, Stryker, Anaconda, Apta Targets, and Perflow Medical and as a speaker for Neuravi. Dr Michel has received funding for speaker honoraria from Boehringer. He has served on scientific advisory boards also for Boehringer. He has received research grants from Bristol-Myers Squibb, Boehringer, and the Swiss Heart Foundation. Dr. Pereira is a consultant for Stryker (SC for DAWN trial), Penumbra (SC for PROMISE study), BALT (proctorship of products unrelated to ischemic stroke), Phenox, Rapid Medical, Neurovasc and receives research a grant from Philips. All other authors declare that there are no conflicts of interest.